Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATLN Atlantic International	$3.96 -0.8%	$2.29	$1.45 ▼ $7.97	$232.92M	1.04	89,941 shs	45,719 shs
NOTE FiscalNote	$0.50 +1.9%	$0.62	$0.48 ▼ $2.03	$77.46M	0.59	2.69 million shs	1.16 million shs
OOMA Ooma	$11.65 +1.1%	$12.07	$8.25 ▼ $17.00	$317.95M	1.21	116,041 shs	106,035 shs
OPRX OptimizeRx	$16.14 +4.2%	$13.91	$3.78 ▼ $18.22	$287.57M	1.33	422,608 shs	249,909 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATLN Atlantic International	-0.75%	+6.74%	+123.73%	+69.23%	+395,999,900.00%
NOTE FiscalNote	+2.04%	-5.31%	-40.17%	-19.90%	-61.47%
OOMA Ooma	+1.35%	+2.51%	-3.68%	-10.13%	+33.70%
OPRX OptimizeRx	+4.20%	-8.24%	+21.35%	+38.54%	+88.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATLN Atlantic International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NOTE FiscalNote	3.3039 of 5 stars	3.6	3.0	0.0	0.0	1.3	3.3	1.3
OOMA Ooma	2.7282 of 5 stars	3.4	2.0	0.0	0.0	2.7	2.5	0.6
OPRX OptimizeRx	1.2343 of 5 stars	1.4	3.0	0.0	0.0	3.1	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATLN Atlantic International	0.00	N/A	N/A	N/A
NOTE FiscalNote	3.20	Buy	$2.44	388.48% Upside
OOMA Ooma	2.80	Moderate Buy	$17.63	51.35% Upside
OPRX OptimizeRx	2.73	Moderate Buy	$11.81	-26.81% Downside

Current Analyst Ratings Breakdown

Latest NOTE, OOMA, OPRX, and ATLN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2025	NOTE FiscalNote	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$3.75
8/11/2025	OPRX OptimizeRx	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$14.00 ➝ $20.00
8/8/2025	OPRX OptimizeRx	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	OPRX OptimizeRx	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$16.00 ➝ $18.00
6/9/2025	OPRX OptimizeRx	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$12.50 ➝ $16.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATLN Atlantic International	$442.61M	0.52	N/A	N/A	($0.24) per share	-16.50
NOTE FiscalNote	$109.68M	0.72	N/A	N/A	$0.60 per share	0.83
OOMA Ooma	$256.85M	1.25	$0.48 per share	24.04	$3.16 per share	3.69
OPRX OptimizeRx	$92.13M	3.25	N/A	N/A	$6.43 per share	2.51

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATLN Atlantic International	-$135.48M	-$2.20	N/A	∞	N/A	-21.93%	-3,234.95%	-79.89%	N/A
NOTE FiscalNote	$9.52M	-$0.32	N/A	N/A	N/A	-41.79%	-61.31%	-19.10%	N/A
OOMA Ooma	-$6.90M	-$0.19	N/A	1,164.50	N/A	-1.89%	2.72%	1.54%	8/26/2025 (Estimated)
OPRX OptimizeRx	-$18.66M	-$0.54	N/A	N/A	2.40	-9.42%	4.50%	3.12%	N/A

Latest NOTE, OOMA, OPRX, and ATLN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/26/2025	Q2 2026	OOMA Ooma	$0.20	N/A	N/A	N/A	$65.77 million	N/A
8/7/2025	Q2 2025	NOTE FiscalNote	-$0.09	-$0.08	+$0.01	-$0.08	$22.83 million	$23.26 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATLN Atlantic International	N/A	N/A	N/A	N/A	N/A
NOTE FiscalNote	N/A	N/A	N/A	N/A	N/A
OOMA Ooma	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATLN Atlantic International	N/A	0.62	0.62
NOTE FiscalNote	1.23	1.25	1.28
OOMA Ooma	N/A	1.16	0.88
OPRX OptimizeRx	0.21	2.57	2.57

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATLN Atlantic International	N/A
NOTE FiscalNote	54.31%
OOMA Ooma	80.42%
OPRX OptimizeRx	76.47%

Insider Ownership

Company	Insider Ownership
ATLN Atlantic International	13.60%
NOTE FiscalNote	37.20%
OOMA Ooma	9.90%
OPRX OptimizeRx	5.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATLN Atlantic International	7	58.38 million	50.44 million	N/A
NOTE FiscalNote	790	158.22 million	99.36 million	Optionable
OOMA Ooma	1,186	27.60 million	24.87 million	Optionable
OPRX OptimizeRx	100	18.57 million	17.53 million	Optionable

NOTE, OOMA, OPRX, and ATLN Headlines

Recent News About These Companies

All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy

August 21 at 1:01 PM | zacks.com

Best Momentum Stock to Buy for August 21st

August 21 at 11:01 AM | zacks.com

OptimizeRx announces leadership team advancements

August 19 at 2:00 PM | msn.com

OptimizeRx Announces Leadership Changes for Strategic Growth

August 19 at 2:00 PM | msn.com

OptimizeRx Corp. Announces Leadership Changes to Enhance Growth Strategy and Profitability

August 19 at 8:11 AM | quiverquant.comQ

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

August 19 at 7:30 AM | globenewswire.com

Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Target Price at $11.81

August 19 at 2:17 AM | americanbankingnews.com

OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Analysts

August 17, 2025 | marketbeat.com

OptimizeRx (NASDAQ:OPRX) Price Target Raised to $20.00

August 14, 2025 | americanbankingnews.com

OptimizeRx Earnings Call: Strong Growth and Positive Outlook

August 13, 2025 | msn.com

OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript

August 12, 2025 | msn.com

JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $20.00

August 12, 2025 | marketbeat.com

OptimizeRx Corp. (OPRX) Stock Price Today - WSJ

August 10, 2025 | wsj.com

Stifel Nicolaus Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock

August 9, 2025 | marketbeat.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: OptimizeRx (OPRX) and Relay Therapeutics (RLAY)

August 9, 2025 | theglobeandmail.com

OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

OptimizeRx Corporation: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

August 8, 2025 | finanznachrichten.de

OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates

August 7, 2025 | zacks.com

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

August 7, 2025 | globenewswire.com

Best Growth Stocks to Buy for August 7th

August 7, 2025 | zacks.com

OptimizeRx Corp. (NASDAQ:OPRX) Shares Bought by Blair William & Co. IL

August 7, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NOTE, OOMA, OPRX, and ATLN Company Descriptions

Atlantic International NASDAQ:ATLN

$3.96 -0.03 (-0.75%)

As of 08/21/2025 04:00 PM Eastern

Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.

FiscalNote NYSE:NOTE

$0.50 +0.01 (+1.92%)

Closing price 08/21/2025 03:59 PM Eastern

Extended Trading

$0.50 +0.00 (+0.20%)

As of 08/21/2025 07:54 PM Eastern

FiscalNote Holdings, Inc. operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. The company also delivers that intelligence through its suite of public policy and issues management products, as well as powerful tools to manage workflows, advocacy campaigns, and constituent relationships. It serves a customer base that includes businesses comprising the Fortune 100 companies, government agencies, law firms, professional services organizations, trade groups, and non-profits. FiscalNote Holdings, Inc. is headquartered in Washington, District Of Columbia.

Ooma NYSE:OOMA

$11.64 +0.13 (+1.09%)

Closing price 08/21/2025 03:59 PM Eastern

Extended Trading

$11.66 +0.01 (+0.09%)

As of 08/21/2025 04:20 PM Eastern

Ooma, Inc. provides communications services and related technologies for businesses and consumers in the United States and Canada. The company's products and services include Ooma Office, a cloud-based multi-user communications system for small and medium-sized businesses; Ooma Connect, which delivers fixed wireless internet connectivity; and Ooma Enterprise, a unified-communications-as-a-service (UCaaS) solution. It also provides Ooma AirDial, a plain old telephone service; PureVoice HD, a residential phone services; Ooma basic that provides unlimited personal calling within the United States; and Ooma Premier, a suite of advanced calling features on a monthly or annual subscription basis. In addition, the company offers Ooma Telo, a home communications solution designed to serve as the primary phone line in the home; Ooma Telo Air, a wireless Ooma Telo with built-in Wi-Fi and Bluetooth; and Ooma Telo LTE, which combines the Ooma Telo base station with the Ooma LTE Adapter and battery back-up. Further, it provides Ooma Mobile HD app that allows users to make and receive phone calls and access Ooma features and settings; 2600Hz provides business communication applications; Talkatone mobile app; and OnSIP, an UCaaS solutions. The company offers its products through direct sales, distributors, retailers, and resellers, as well as online and sale representatives. Ooma, Inc. was incorporated in 2003 and is headquartered in Sunnyvale, California.

OptimizeRx NASDAQ:OPRX

$16.14 +0.65 (+4.20%)

Closing price 08/21/2025 04:00 PM Eastern

Extended Trading

$16.19 +0.05 (+0.31%)

As of 08/21/2025 06:56 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time